Literature DB >> 6254085

Expression of cloned hepatitis B virus DNA in human cell cultures.

S Z Hirschman, P Price, E Garfinkel, J Christman, G Acs.   

Abstract

DNA was isolated from the ayw subtype of hepatitis B virus (HBV) that had been incubated in vitro with all four deoxynucleoside triphosphates in order to complete the circular viral genome by means of the endogenous DNA polymerase. The purified viral DNA was cleaved with EcoRI restriction endonuclease, inserted into the EcoRI site of plasmid pBR322, and cloned in Escherichia coli chi 1776. DNA from a clone, pHBV-1, that contained a 3200-base-pair insert of HBV DNA was cleaved with EcoRI and incubated with phage T4 ligase under conditions favoring intramolecular ligation. HeLa cell cultures exposed to this DNA showed marked cytopathic changes, accompanied by production of hepatitis B core and surface antigens, 11-14 days after subculture. Electron microscopic examination of anti-hepatitis B surface antigen immunoprecipitates from culture media of these cells revealed both 42-nm particles with central cores and 20-nm round particles. Although neither intact circular nor EcoRI-cleaved linear pHBV-1 DNAs evoked these effects in HeLa cells, both cytopathic changes and intranuclear hepatitis B core antigen were detected in HeLa cells infected with Dane particles.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254085      PMCID: PMC350090          DOI: 10.1073/pnas.77.9.5507

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Demonstration of hepatitis B e antigen in the core of Dane particles.

Authors:  K Takahashi; Y Akahane; T Gotanda; T Mishiro; M Imai; Y Miyakawa; M Mayumi
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

2.  Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles.

Authors:  J Summers; A O'Connell; I Millman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

3.  Ionic requirements of the DNA polymerase associated with serum hepatitis B antigen.

Authors:  S Z Hirschman; E Garfinkel
Journal:  J Infect Dis       Date:  1977-06       Impact factor: 5.226

Review 4.  The genome of hepatitis B virus.

Authors:  W S Robinson
Journal:  Annu Rev Microbiol       Date:  1977       Impact factor: 15.500

5.  Virus-like particles in serum of patients with Australia-antigen-associated hepatitis.

Authors:  D S Dane; C H Cameron; M Briggs
Journal:  Lancet       Date:  1970-04-04       Impact factor: 79.321

6.  Purification of naked intranuclear particles from human liver infected by hepatitis B virus.

Authors:  S Z Hirschman; M Gerber; E Garfinkel
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

7.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

8.  Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody.

Authors:  C M Ling; L R Overby
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

9.  Rat insulin genes: construction of plasmids containing the coding sequences.

Authors:  A Ullrich; J Shine; J Chirgwin; R Pictet; E Tischer; W J Rutter; H M Goodman
Journal:  Science       Date:  1977-06-17       Impact factor: 47.728

10.  Serotypes of hepatitis B antigen (HBs Ag): the problem of "new" determinants, as exemplified by "t".

Authors:  G L Bouvier; A Williams
Journal:  Am J Med Sci       Date:  1975 Jul-Aug       Impact factor: 2.378

View more
  30 in total

1.  Improved method for rapid and efficient determination of genome replication and protein expression of clinical hepatitis B virus isolates.

Authors:  Yanli Qin; Jiming Zhang; Tamako Garcia; Kiyoaki Ito; Danielle Gutelius; Jisu Li; Jack Wands; Shuping Tong
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

2.  Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.

Authors:  Simone Grasso; Luca Santi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-07-06

3.  Infectious hepatitis B virus from cloned DNA of known nucleotide sequence.

Authors:  H Will; R Cattaneo; G Darai; F Deinhardt; H Schellekens; H Schaller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

Review 4.  Hepatitis B virus components produced by the human hepatoma cell line PLC/PRF/5: do they indicate virus propagation? Brief review.

Authors:  O Marquardt
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

5.  Expression of hepatitis B antigens with a simian virus 40 vector.

Authors:  H Will; R Cattaneo; E Pfaff; C Kuhn; M Roggendorf; H Schaller
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

6.  Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.

Authors:  E Paoletti; B R Lipinskas; C Samsonoff; S Mercer; D Panicali
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

7.  Expression of hepatitis B virus surface antigen gene in cultured cells by using recombinant plasmid vectors.

Authors:  A Siddiqui
Journal:  Mol Cell Biol       Date:  1983-01       Impact factor: 4.272

8.  Transcription of the hepatitis B surface antigen gene in mouse cells transformed with cloned viral DNA.

Authors:  C Pourcel; A Louise; M Gervais; N Chenciner; M F Dubois; P Tiollais
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

9.  Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide.

Authors:  P Gripon; C Diot; N Thézé; I Fourel; O Loreal; C Brechot; C Guguen-Guillouzo
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

10.  Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus.

Authors:  Marjoleine L Op den Brouw; Rekha S Binda; Mark H van Roosmalen; Ulrike Protzer; Harry L A Janssen; Renate G van der Molen; Andrea M Woltman
Journal:  Immunology       Date:  2008-06-28       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.